nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Skin disorder—Gemcitabine—pancreatic cancer	0.000858	0.00133	CcSEcCtD
Remifentanil—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000854	0.00133	CcSEcCtD
Remifentanil—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000852	0.00132	CcSEcCtD
Remifentanil—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000851	0.00132	CcSEcCtD
Remifentanil—Visual impairment—Docetaxel—pancreatic cancer	0.000851	0.00132	CcSEcCtD
Remifentanil—Dizziness—Tamoxifen—pancreatic cancer	0.00085	0.00132	CcSEcCtD
Remifentanil—Tachycardia—Fluorouracil—pancreatic cancer	0.000848	0.00132	CcSEcCtD
Remifentanil—Hypotension—Irinotecan—pancreatic cancer	0.000848	0.00132	CcSEcCtD
Remifentanil—Dizziness—Erlotinib—pancreatic cancer	0.000841	0.00131	CcSEcCtD
Remifentanil—Renal impairment—Doxorubicin—pancreatic cancer	0.000837	0.0013	CcSEcCtD
Remifentanil—Hypotension—Gemcitabine—pancreatic cancer	0.000826	0.00128	CcSEcCtD
Remifentanil—Cardiac disorder—Docetaxel—pancreatic cancer	0.000819	0.00127	CcSEcCtD
Remifentanil—Flushing—Docetaxel—pancreatic cancer	0.000819	0.00127	CcSEcCtD
Remifentanil—Cardiac arrest—Epirubicin—pancreatic cancer	0.000818	0.00127	CcSEcCtD
Remifentanil—Vomiting—Tamoxifen—pancreatic cancer	0.000818	0.00127	CcSEcCtD
Remifentanil—Paraesthesia—Irinotecan—pancreatic cancer	0.000815	0.00127	CcSEcCtD
Remifentanil—Hypotension—Fluorouracil—pancreatic cancer	0.000812	0.00126	CcSEcCtD
Remifentanil—Hypersensitivity—Sunitinib—pancreatic cancer	0.000811	0.00126	CcSEcCtD
Remifentanil—Rash—Tamoxifen—pancreatic cancer	0.000811	0.00126	CcSEcCtD
Remifentanil—Dermatitis—Tamoxifen—pancreatic cancer	0.00081	0.00126	CcSEcCtD
Remifentanil—Vomiting—Erlotinib—pancreatic cancer	0.000809	0.00126	CcSEcCtD
Remifentanil—Dyspnoea—Irinotecan—pancreatic cancer	0.000809	0.00126	CcSEcCtD
Remifentanil—Somnolence—Irinotecan—pancreatic cancer	0.000806	0.00125	CcSEcCtD
Remifentanil—Headache—Tamoxifen—pancreatic cancer	0.000806	0.00125	CcSEcCtD
Remifentanil—Rash—Erlotinib—pancreatic cancer	0.000802	0.00125	CcSEcCtD
Remifentanil—Dermatitis—Erlotinib—pancreatic cancer	0.000801	0.00125	CcSEcCtD
Remifentanil—Angiopathy—Docetaxel—pancreatic cancer	0.000801	0.00124	CcSEcCtD
Remifentanil—Dyspepsia—Irinotecan—pancreatic cancer	0.000799	0.00124	CcSEcCtD
Remifentanil—Immune system disorder—Docetaxel—pancreatic cancer	0.000797	0.00124	CcSEcCtD
Remifentanil—Headache—Erlotinib—pancreatic cancer	0.000797	0.00124	CcSEcCtD
Remifentanil—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000796	0.00124	CcSEcCtD
Remifentanil—Paraesthesia—Gemcitabine—pancreatic cancer	0.000793	0.00123	CcSEcCtD
Remifentanil—Chills—Docetaxel—pancreatic cancer	0.000792	0.00123	CcSEcCtD
Remifentanil—Arrhythmia—Docetaxel—pancreatic cancer	0.000789	0.00123	CcSEcCtD
Remifentanil—Dyspnoea—Gemcitabine—pancreatic cancer	0.000788	0.00122	CcSEcCtD
Remifentanil—Somnolence—Gemcitabine—pancreatic cancer	0.000786	0.00122	CcSEcCtD
Remifentanil—Hypokalaemia—Epirubicin—pancreatic cancer	0.000783	0.00122	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000783	0.00122	CcSEcCtD
Remifentanil—Paraesthesia—Fluorouracil—pancreatic cancer	0.00078	0.00121	CcSEcCtD
Remifentanil—Pruritus—Sunitinib—pancreatic cancer	0.000779	0.00121	CcSEcCtD
Remifentanil—Constipation—Irinotecan—pancreatic cancer	0.000776	0.00121	CcSEcCtD
Remifentanil—Pain—Irinotecan—pancreatic cancer	0.000776	0.00121	CcSEcCtD
Remifentanil—Dyspnoea—Fluorouracil—pancreatic cancer	0.000775	0.0012	CcSEcCtD
Remifentanil—Somnolence—Fluorouracil—pancreatic cancer	0.000772	0.0012	CcSEcCtD
Remifentanil—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00077	0.0012	CcSEcCtD
Remifentanil—Erythema—Docetaxel—pancreatic cancer	0.000768	0.00119	CcSEcCtD
Remifentanil—Dyspepsia—Fluorouracil—pancreatic cancer	0.000765	0.00119	CcSEcCtD
Remifentanil—Nausea—Tamoxifen—pancreatic cancer	0.000764	0.00119	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000763	0.00119	CcSEcCtD
Remifentanil—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000757	0.00118	CcSEcCtD
Remifentanil—Constipation—Gemcitabine—pancreatic cancer	0.000756	0.00117	CcSEcCtD
Remifentanil—Pain—Gemcitabine—pancreatic cancer	0.000756	0.00117	CcSEcCtD
Remifentanil—Nausea—Erlotinib—pancreatic cancer	0.000756	0.00117	CcSEcCtD
Remifentanil—Diarrhoea—Sunitinib—pancreatic cancer	0.000754	0.00117	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00075	0.00117	CcSEcCtD
Remifentanil—Feeling abnormal—Irinotecan—pancreatic cancer	0.000748	0.00116	CcSEcCtD
Remifentanil—Dysphagia—Epirubicin—pancreatic cancer	0.000744	0.00116	CcSEcCtD
Remifentanil—Pain—Fluorouracil—pancreatic cancer	0.000743	0.00115	CcSEcCtD
Remifentanil—Dizziness—Sunitinib—pancreatic cancer	0.000728	0.00113	CcSEcCtD
Remifentanil—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000728	0.00113	CcSEcCtD
Remifentanil—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000725	0.00113	CcSEcCtD
Remifentanil—Body temperature increased—Irinotecan—pancreatic cancer	0.000717	0.00111	CcSEcCtD
Remifentanil—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000716	0.00111	CcSEcCtD
Remifentanil—Bronchitis—Epirubicin—pancreatic cancer	0.000715	0.00111	CcSEcCtD
Remifentanil—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000712	0.00111	CcSEcCtD
Remifentanil—Anaemia—Docetaxel—pancreatic cancer	0.00071	0.0011	CcSEcCtD
Remifentanil—Vomiting—Sunitinib—pancreatic cancer	0.0007	0.00109	CcSEcCtD
Remifentanil—Body temperature increased—Gemcitabine—pancreatic cancer	0.000699	0.00109	CcSEcCtD
Remifentanil—Dysuria—Epirubicin—pancreatic cancer	0.000696	0.00108	CcSEcCtD
Remifentanil—Rash—Sunitinib—pancreatic cancer	0.000694	0.00108	CcSEcCtD
Remifentanil—Dermatitis—Sunitinib—pancreatic cancer	0.000694	0.00108	CcSEcCtD
Remifentanil—Urticaria—Fluorouracil—pancreatic cancer	0.00069	0.00107	CcSEcCtD
Remifentanil—Headache—Sunitinib—pancreatic cancer	0.00069	0.00107	CcSEcCtD
Remifentanil—Syncope—Docetaxel—pancreatic cancer	0.000689	0.00107	CcSEcCtD
Remifentanil—Dysphagia—Doxorubicin—pancreatic cancer	0.000688	0.00107	CcSEcCtD
Remifentanil—Body temperature increased—Fluorouracil—pancreatic cancer	0.000687	0.00107	CcSEcCtD
Remifentanil—Loss of consciousness—Docetaxel—pancreatic cancer	0.000675	0.00105	CcSEcCtD
Remifentanil—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000671	0.00104	CcSEcCtD
Remifentanil—Cough—Docetaxel—pancreatic cancer	0.000671	0.00104	CcSEcCtD
Remifentanil—Hypersensitivity—Irinotecan—pancreatic cancer	0.000668	0.00104	CcSEcCtD
Remifentanil—Pneumonia—Epirubicin—pancreatic cancer	0.000667	0.00104	CcSEcCtD
Remifentanil—Convulsion—Docetaxel—pancreatic cancer	0.000666	0.00103	CcSEcCtD
Remifentanil—Hypertension—Docetaxel—pancreatic cancer	0.000663	0.00103	CcSEcCtD
Remifentanil—Bronchitis—Doxorubicin—pancreatic cancer	0.000662	0.00103	CcSEcCtD
Remifentanil—Nausea—Sunitinib—pancreatic cancer	0.000654	0.00102	CcSEcCtD
Remifentanil—Renal failure—Epirubicin—pancreatic cancer	0.000652	0.00101	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00065	0.00101	CcSEcCtD
Remifentanil—Dysuria—Doxorubicin—pancreatic cancer	0.000644	0.001	CcSEcCtD
Remifentanil—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00064	0.000995	CcSEcCtD
Remifentanil—Dry mouth—Docetaxel—pancreatic cancer	0.00064	0.000994	CcSEcCtD
Remifentanil—Sweating—Epirubicin—pancreatic cancer	0.000636	0.000988	CcSEcCtD
Remifentanil—Haematuria—Epirubicin—pancreatic cancer	0.000632	0.000983	CcSEcCtD
Remifentanil—Confusional state—Docetaxel—pancreatic cancer	0.000632	0.000983	CcSEcCtD
Remifentanil—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000627	0.000975	CcSEcCtD
Remifentanil—Oedema—Docetaxel—pancreatic cancer	0.000627	0.000975	CcSEcCtD
Remifentanil—Pruritus—Gemcitabine—pancreatic cancer	0.000625	0.000972	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000621	0.000965	CcSEcCtD
Remifentanil—Diarrhoea—Irinotecan—pancreatic cancer	0.000621	0.000965	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—pancreatic cancer	0.000617	0.000959	CcSEcCtD
Remifentanil—Shock—Docetaxel—pancreatic cancer	0.000617	0.000959	CcSEcCtD
Remifentanil—Nervous system disorder—Docetaxel—pancreatic cancer	0.000615	0.000956	CcSEcCtD
Remifentanil—Pruritus—Fluorouracil—pancreatic cancer	0.000615	0.000955	CcSEcCtD
Remifentanil—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000614	0.000954	CcSEcCtD
Remifentanil—Tachycardia—Docetaxel—pancreatic cancer	0.000612	0.000951	CcSEcCtD
Remifentanil—Skin disorder—Docetaxel—pancreatic cancer	0.000609	0.000947	CcSEcCtD
Remifentanil—Bradycardia—Epirubicin—pancreatic cancer	0.000606	0.000942	CcSEcCtD
Remifentanil—Diarrhoea—Gemcitabine—pancreatic cancer	0.000605	0.00094	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—pancreatic cancer	0.000603	0.000937	CcSEcCtD
Remifentanil—Dizziness—Irinotecan—pancreatic cancer	0.0006	0.000932	CcSEcCtD
Remifentanil—Haemoglobin—Epirubicin—pancreatic cancer	0.000598	0.00093	CcSEcCtD
Remifentanil—Haemorrhage—Epirubicin—pancreatic cancer	0.000595	0.000925	CcSEcCtD
Remifentanil—Diarrhoea—Fluorouracil—pancreatic cancer	0.000594	0.000924	CcSEcCtD
Remifentanil—Pharyngitis—Epirubicin—pancreatic cancer	0.000591	0.000918	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—pancreatic cancer	0.000588	0.000914	CcSEcCtD
Remifentanil—Hypotension—Docetaxel—pancreatic cancer	0.000586	0.000911	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—pancreatic cancer	0.000585	0.000909	CcSEcCtD
Remifentanil—Vomiting—Irinotecan—pancreatic cancer	0.000577	0.000896	CcSEcCtD
Remifentanil—Dizziness—Fluorouracil—pancreatic cancer	0.000575	0.000893	CcSEcCtD
Remifentanil—Visual impairment—Epirubicin—pancreatic cancer	0.000574	0.000892	CcSEcCtD
Remifentanil—Rash—Irinotecan—pancreatic cancer	0.000572	0.000889	CcSEcCtD
Remifentanil—Dermatitis—Irinotecan—pancreatic cancer	0.000571	0.000888	CcSEcCtD
Remifentanil—Headache—Irinotecan—pancreatic cancer	0.000568	0.000883	CcSEcCtD
Remifentanil—Paraesthesia—Docetaxel—pancreatic cancer	0.000563	0.000875	CcSEcCtD
Remifentanil—Vomiting—Gemcitabine—pancreatic cancer	0.000562	0.000873	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—pancreatic cancer	0.000561	0.000872	CcSEcCtD
Remifentanil—Dyspnoea—Docetaxel—pancreatic cancer	0.000559	0.000869	CcSEcCtD
Remifentanil—Somnolence—Docetaxel—pancreatic cancer	0.000557	0.000866	CcSEcCtD
Remifentanil—Rash—Gemcitabine—pancreatic cancer	0.000557	0.000866	CcSEcCtD
Remifentanil—Dermatitis—Gemcitabine—pancreatic cancer	0.000557	0.000865	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—pancreatic cancer	0.000554	0.00086	CcSEcCtD
Remifentanil—Headache—Gemcitabine—pancreatic cancer	0.000554	0.00086	CcSEcCtD
Remifentanil—Cardiac disorder—Epirubicin—pancreatic cancer	0.000553	0.000859	CcSEcCtD
Remifentanil—Flushing—Epirubicin—pancreatic cancer	0.000553	0.000859	CcSEcCtD
Remifentanil—Vomiting—Fluorouracil—pancreatic cancer	0.000552	0.000859	CcSEcCtD
Remifentanil—Dyspepsia—Docetaxel—pancreatic cancer	0.000552	0.000858	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—pancreatic cancer	0.000551	0.000856	CcSEcCtD
Remifentanil—Rash—Fluorouracil—pancreatic cancer	0.000548	0.000851	CcSEcCtD
Remifentanil—Dermatitis—Fluorouracil—pancreatic cancer	0.000547	0.000851	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—pancreatic cancer	0.000547	0.00085	CcSEcCtD
Remifentanil—Headache—Fluorouracil—pancreatic cancer	0.000544	0.000846	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000541	0.000841	CcSEcCtD
Remifentanil—Angiopathy—Epirubicin—pancreatic cancer	0.00054	0.000839	CcSEcCtD
Remifentanil—Nausea—Irinotecan—pancreatic cancer	0.000539	0.000837	CcSEcCtD
Remifentanil—Immune system disorder—Epirubicin—pancreatic cancer	0.000538	0.000836	CcSEcCtD
Remifentanil—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000537	0.000834	CcSEcCtD
Remifentanil—Pain—Docetaxel—pancreatic cancer	0.000536	0.000833	CcSEcCtD
Remifentanil—Constipation—Docetaxel—pancreatic cancer	0.000536	0.000833	CcSEcCtD
Remifentanil—Chills—Epirubicin—pancreatic cancer	0.000534	0.00083	CcSEcCtD
Remifentanil—Arrhythmia—Epirubicin—pancreatic cancer	0.000532	0.000827	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—pancreatic cancer	0.000531	0.000825	CcSEcCtD
Remifentanil—Nausea—Gemcitabine—pancreatic cancer	0.000525	0.000816	CcSEcCtD
Remifentanil—Erythema—Epirubicin—pancreatic cancer	0.000518	0.000805	CcSEcCtD
Remifentanil—Feeling abnormal—Docetaxel—pancreatic cancer	0.000517	0.000803	CcSEcCtD
Remifentanil—Nausea—Fluorouracil—pancreatic cancer	0.000516	0.000802	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000511	0.000795	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—pancreatic cancer	0.000511	0.000795	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—pancreatic cancer	0.0005	0.000777	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—pancreatic cancer	0.000498	0.000773	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000496	0.000772	CcSEcCtD
Remifentanil—Body temperature increased—Docetaxel—pancreatic cancer	0.000496	0.00077	CcSEcCtD
Remifentanil—Chills—Doxorubicin—pancreatic cancer	0.000494	0.000768	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—pancreatic cancer	0.000492	0.000765	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—pancreatic cancer	0.00048	0.000745	CcSEcCtD
Remifentanil—Anaemia—Epirubicin—pancreatic cancer	0.000479	0.000744	CcSEcCtD
Remifentanil—Agitation—Epirubicin—pancreatic cancer	0.000476	0.00074	CcSEcCtD
Remifentanil—Syncope—Epirubicin—pancreatic cancer	0.000465	0.000722	CcSEcCtD
Remifentanil—Hypersensitivity—Docetaxel—pancreatic cancer	0.000462	0.000718	CcSEcCtD
Remifentanil—Loss of consciousness—Epirubicin—pancreatic cancer	0.000456	0.000708	CcSEcCtD
Remifentanil—Cough—Epirubicin—pancreatic cancer	0.000452	0.000703	CcSEcCtD
Remifentanil—Convulsion—Epirubicin—pancreatic cancer	0.000449	0.000698	CcSEcCtD
Remifentanil—Hypertension—Epirubicin—pancreatic cancer	0.000447	0.000695	CcSEcCtD
Remifentanil—Pruritus—Docetaxel—pancreatic cancer	0.000444	0.000689	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—pancreatic cancer	0.000443	0.000689	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—pancreatic cancer	0.000441	0.000685	CcSEcCtD
Remifentanil—Anxiety—Epirubicin—pancreatic cancer	0.00044	0.000683	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000438	0.000681	CcSEcCtD
Remifentanil—Dry mouth—Epirubicin—pancreatic cancer	0.000432	0.000671	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—pancreatic cancer	0.00043	0.000668	CcSEcCtD
Remifentanil—Diarrhoea—Docetaxel—pancreatic cancer	0.000429	0.000667	CcSEcCtD
Remifentanil—Confusional state—Epirubicin—pancreatic cancer	0.000426	0.000663	CcSEcCtD
Remifentanil—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000423	0.000657	CcSEcCtD
Remifentanil—Oedema—Epirubicin—pancreatic cancer	0.000423	0.000657	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000421	0.000655	CcSEcCtD
Remifentanil—Cough—Doxorubicin—pancreatic cancer	0.000418	0.00065	CcSEcCtD
Remifentanil—Shock—Epirubicin—pancreatic cancer	0.000416	0.000647	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—pancreatic cancer	0.000415	0.000646	CcSEcCtD
Remifentanil—Nervous system disorder—Epirubicin—pancreatic cancer	0.000415	0.000645	CcSEcCtD
Remifentanil—Dizziness—Docetaxel—pancreatic cancer	0.000415	0.000644	CcSEcCtD
Remifentanil—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000414	0.000644	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—pancreatic cancer	0.000414	0.000643	CcSEcCtD
Remifentanil—Tachycardia—Epirubicin—pancreatic cancer	0.000413	0.000642	CcSEcCtD
Remifentanil—Skin disorder—Epirubicin—pancreatic cancer	0.000411	0.000638	CcSEcCtD
Remifentanil—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000409	0.000635	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—pancreatic cancer	0.000407	0.000632	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000405	0.00063	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—pancreatic cancer	0.000399	0.000621	CcSEcCtD
Remifentanil—Vomiting—Docetaxel—pancreatic cancer	0.000399	0.00062	CcSEcCtD
Remifentanil—Rash—Docetaxel—pancreatic cancer	0.000395	0.000614	CcSEcCtD
Remifentanil—Hypotension—Epirubicin—pancreatic cancer	0.000395	0.000614	CcSEcCtD
Remifentanil—Dermatitis—Docetaxel—pancreatic cancer	0.000395	0.000614	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—pancreatic cancer	0.000395	0.000613	CcSEcCtD
Remifentanil—Headache—Docetaxel—pancreatic cancer	0.000393	0.000611	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000391	0.000608	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—pancreatic cancer	0.000391	0.000608	CcSEcCtD
Remifentanil—Shock—Doxorubicin—pancreatic cancer	0.000385	0.000598	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000384	0.000596	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000383	0.000596	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—pancreatic cancer	0.000382	0.000594	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—pancreatic cancer	0.00038	0.000591	CcSEcCtD
Remifentanil—Paraesthesia—Epirubicin—pancreatic cancer	0.00038	0.00059	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000378	0.000588	CcSEcCtD
Remifentanil—Dyspnoea—Epirubicin—pancreatic cancer	0.000377	0.000586	CcSEcCtD
Remifentanil—Somnolence—Epirubicin—pancreatic cancer	0.000376	0.000584	CcSEcCtD
Remifentanil—Nausea—Docetaxel—pancreatic cancer	0.000372	0.000579	CcSEcCtD
Remifentanil—Dyspepsia—Epirubicin—pancreatic cancer	0.000372	0.000579	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—pancreatic cancer	0.000366	0.000568	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000365	0.000568	CcSEcCtD
Remifentanil—Pain—Epirubicin—pancreatic cancer	0.000362	0.000562	CcSEcCtD
Remifentanil—Constipation—Epirubicin—pancreatic cancer	0.000362	0.000562	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—pancreatic cancer	0.000351	0.000546	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—pancreatic cancer	0.000349	0.000542	CcSEcCtD
Remifentanil—Feeling abnormal—Epirubicin—pancreatic cancer	0.000349	0.000542	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—pancreatic cancer	0.000348	0.000541	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—pancreatic cancer	0.000345	0.000535	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000338	0.000525	CcSEcCtD
Remifentanil—Urticaria—Epirubicin—pancreatic cancer	0.000336	0.000522	CcSEcCtD
Remifentanil—Pain—Doxorubicin—pancreatic cancer	0.000335	0.00052	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—pancreatic cancer	0.000335	0.00052	CcSEcCtD
Remifentanil—Body temperature increased—Epirubicin—pancreatic cancer	0.000334	0.00052	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000323	0.000501	CcSEcCtD
Remifentanil—Hypersensitivity—Epirubicin—pancreatic cancer	0.000312	0.000484	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—pancreatic cancer	0.000311	0.000483	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—pancreatic cancer	0.000309	0.000481	CcSEcCtD
Remifentanil—Pruritus—Epirubicin—pancreatic cancer	0.000299	0.000465	CcSEcCtD
Remifentanil—Diarrhoea—Epirubicin—pancreatic cancer	0.000289	0.00045	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000288	0.000448	CcSEcCtD
Remifentanil—OPRK1—Signaling Pathways—SSTR2—pancreatic cancer	0.000286	0.000802	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000281	0.000787	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GCG—pancreatic cancer	0.00028	0.000786	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CNR1—pancreatic cancer	0.00028	0.000786	CbGpPWpGaD
Remifentanil—Dizziness—Epirubicin—pancreatic cancer	0.00028	0.000435	CcSEcCtD
Remifentanil—OPRD1—Signaling Pathways—HEY2—pancreatic cancer	0.000277	0.000778	CbGpPWpGaD
Remifentanil—Pruritus—Doxorubicin—pancreatic cancer	0.000277	0.00043	CcSEcCtD
Remifentanil—OPRK1—Signaling Pathways—CCKBR—pancreatic cancer	0.000276	0.000775	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—SST—pancreatic cancer	0.000276	0.000773	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000275	0.000771	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GAST—pancreatic cancer	0.000271	0.00076	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GCG—pancreatic cancer	0.000271	0.000759	CbGpPWpGaD
Remifentanil—Vomiting—Epirubicin—pancreatic cancer	0.000269	0.000418	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—SHH—pancreatic cancer	0.000269	0.000754	CbGpPWpGaD
Remifentanil—Diarrhoea—Doxorubicin—pancreatic cancer	0.000268	0.000416	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000267	0.00075	CbGpPWpGaD
Remifentanil—Rash—Epirubicin—pancreatic cancer	0.000267	0.000414	CcSEcCtD
Remifentanil—Dermatitis—Epirubicin—pancreatic cancer	0.000266	0.000414	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—IAPP—pancreatic cancer	0.000265	0.000744	CbGpPWpGaD
Remifentanil—Headache—Epirubicin—pancreatic cancer	0.000265	0.000412	CcSEcCtD
Remifentanil—OPRM1—Signaling Pathways—SSTR3—pancreatic cancer	0.000262	0.000735	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DTX1—pancreatic cancer	0.000262	0.000735	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DTX4—pancreatic cancer	0.00026	0.000729	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GLI1—pancreatic cancer	0.00026	0.000729	CbGpPWpGaD
Remifentanil—Dizziness—Doxorubicin—pancreatic cancer	0.000259	0.000402	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000258	0.000724	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SCT—pancreatic cancer	0.000257	0.00072	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HEY1—pancreatic cancer	0.000257	0.00072	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—SST—pancreatic cancer	0.000257	0.00072	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000255	0.000714	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000255	0.000714	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CNR1—pancreatic cancer	0.000254	0.000714	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NRP1—pancreatic cancer	0.000253	0.000709	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000253	0.000709	CbGpPWpGaD
Remifentanil—Nausea—Epirubicin—pancreatic cancer	0.000251	0.00039	CcSEcCtD
Remifentanil—OPRM1—Signaling Pathways—SSTR1—pancreatic cancer	0.000251	0.000705	CbGpPWpGaD
Remifentanil—Vomiting—Doxorubicin—pancreatic cancer	0.000249	0.000387	CcSEcCtD
Remifentanil—Rash—Doxorubicin—pancreatic cancer	0.000247	0.000383	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—pancreatic cancer	0.000247	0.000383	CcSEcCtD
Remifentanil—OPRM1—Signaling Pathways—PPY—pancreatic cancer	0.000246	0.000691	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GCG—pancreatic cancer	0.000246	0.000689	CbGpPWpGaD
Remifentanil—Headache—Doxorubicin—pancreatic cancer	0.000245	0.000381	CcSEcCtD
Remifentanil—OPRD1—Signaling Pathways—CCK—pancreatic cancer	0.000245	0.000687	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HEY2—pancreatic cancer	0.000243	0.000682	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SSTR2—pancreatic cancer	0.000242	0.000678	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CNR2—pancreatic cancer	0.000239	0.00067	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GLP1R—pancreatic cancer	0.000239	0.00067	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000239	0.000669	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GAST—pancreatic cancer	0.000238	0.000666	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000237	0.000664	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCKAR—pancreatic cancer	0.000235	0.000659	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000234	0.000657	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCKBR—pancreatic cancer	0.000234	0.000655	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—SST—pancreatic cancer	0.000233	0.000653	CbGpPWpGaD
Remifentanil—Nausea—Doxorubicin—pancreatic cancer	0.000232	0.000361	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000232	0.000651	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GCG—pancreatic cancer	0.000229	0.000641	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JAG2—pancreatic cancer	0.000228	0.000639	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SCT—pancreatic cancer	0.000225	0.000632	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HEY1—pancreatic cancer	0.000225	0.000632	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MEN1—pancreatic cancer	0.000225	0.00063	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GLI1—pancreatic cancer	0.00022	0.000616	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DTX4—pancreatic cancer	0.00022	0.000616	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000218	0.000612	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CNR1—pancreatic cancer	0.000215	0.000603	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCK—pancreatic cancer	0.000215	0.000603	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SHH—pancreatic cancer	0.000214	0.000601	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000214	0.000599	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NRP1—pancreatic cancer	0.000214	0.000599	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000213	0.000597	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IAPP—pancreatic cancer	0.000212	0.000593	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CNR2—pancreatic cancer	0.000209	0.000587	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GLP1R—pancreatic cancer	0.000209	0.000587	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000209	0.000587	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GCG—pancreatic cancer	0.000208	0.000582	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCKAR—pancreatic cancer	0.000206	0.000578	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HEY2—pancreatic cancer	0.000206	0.000577	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTHLH—pancreatic cancer	0.000203	0.00057	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTCH1—pancreatic cancer	0.000203	0.00057	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GAST—pancreatic cancer	0.000201	0.000563	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JAG2—pancreatic cancer	0.0002	0.00056	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000198	0.000556	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MEN1—pancreatic cancer	0.000197	0.000552	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SCT—pancreatic cancer	0.00019	0.000534	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HEY1—pancreatic cancer	0.00019	0.000534	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SHH—pancreatic cancer	0.000188	0.000527	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000187	0.000524	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SST—pancreatic cancer	0.000186	0.000521	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IAPP—pancreatic cancer	0.000185	0.00052	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000183	0.000514	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JAG1—pancreatic cancer	0.000182	0.00051	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCK—pancreatic cancer	0.000182	0.000509	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000181	0.000508	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTHLH—pancreatic cancer	0.000178	0.000499	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTCH1—pancreatic cancer	0.000178	0.000499	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CNR2—pancreatic cancer	0.000177	0.000496	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GLP1R—pancreatic cancer	0.000177	0.000496	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000177	0.000496	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCKAR—pancreatic cancer	0.000174	0.000488	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CNR1—pancreatic cancer	0.000171	0.000481	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JAG2—pancreatic cancer	0.000169	0.000474	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MEN1—pancreatic cancer	0.000166	0.000467	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000166	0.000467	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GCG—pancreatic cancer	0.000166	0.000464	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SST—pancreatic cancer	0.000163	0.000457	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000161	0.000452	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000161	0.00045	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JAG1—pancreatic cancer	0.000159	0.000447	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SHH—pancreatic cancer	0.000159	0.000445	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000159	0.000445	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGTR1—pancreatic cancer	0.000158	0.000443	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000158	0.000442	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IAPP—pancreatic cancer	0.000157	0.00044	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STK11—pancreatic cancer	0.000156	0.000437	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTHLH—pancreatic cancer	0.00015	0.000422	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	0.00015	0.000422	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	0.00015	0.000422	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000146	0.00041	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000146	0.000409	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GCG—pancreatic cancer	0.000145	0.000407	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000141	0.000396	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00014	0.000394	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	0.000138	0.000388	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SST—pancreatic cancer	0.000138	0.000386	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STK11—pancreatic cancer	0.000136	0.000383	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SMAD4—pancreatic cancer	0.000136	0.000382	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000136	0.000381	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000135	0.000378	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	0.000135	0.000378	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000134	0.000376	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HES1—pancreatic cancer	0.000133	0.000373	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000128	0.00036	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000127	0.000357	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	0.000127	0.000356	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000123	0.000346	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000123	0.000345	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GCG—pancreatic cancer	0.000123	0.000344	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000122	0.000344	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	0.00012	0.000335	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000119	0.000335	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000118	0.000332	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	0.000117	0.000328	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HES1—pancreatic cancer	0.000117	0.000327	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TERT—pancreatic cancer	0.000117	0.000327	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STK11—pancreatic cancer	0.000115	0.000324	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000112	0.000313	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	0.000112	0.000313	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	0.000111	0.000312	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOE—pancreatic cancer	0.000109	0.000305	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000108	0.000304	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000107	0.000301	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KDR—pancreatic cancer	0.000107	0.000299	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000104	0.000292	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TERT—pancreatic cancer	0.000102	0.000287	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000101	0.000285	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	0.000101	0.000283	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	0.0001	0.000282	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.0001	0.00028	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HES1—pancreatic cancer	9.86e-05	0.000277	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	9.83e-05	0.000276	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	9.83e-05	0.000276	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	9.78e-05	0.000274	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	9.76e-05	0.000274	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGF—pancreatic cancer	9.71e-05	0.000272	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOE—pancreatic cancer	9.55e-05	0.000268	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	9.45e-05	0.000265	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KDR—pancreatic cancer	9.35e-05	0.000262	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	9.08e-05	0.000255	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	8.95e-05	0.000251	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	8.9e-05	0.00025	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	8.81e-05	0.000247	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TERT—pancreatic cancer	8.64e-05	0.000242	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	8.64e-05	0.000242	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	8.62e-05	0.000242	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	8.62e-05	0.000242	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.56e-05	0.00024	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGF—pancreatic cancer	8.52e-05	0.000239	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	8.46e-05	0.000237	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	8.27e-05	0.000232	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	8.25e-05	0.000231	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOE—pancreatic cancer	8.07e-05	0.000226	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KDR—pancreatic cancer	7.91e-05	0.000222	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	7.85e-05	0.00022	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	7.77e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	7.57e-05	0.000212	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	7.53e-05	0.000211	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	7.52e-05	0.000211	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.5e-05	0.00021	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	7.45e-05	0.000209	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	7.42e-05	0.000208	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	7.28e-05	0.000204	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	7.28e-05	0.000204	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	7.24e-05	0.000203	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGF—pancreatic cancer	7.2e-05	0.000202	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	7.19e-05	0.000202	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	6.99e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	6.93e-05	0.000194	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	6.81e-05	0.000191	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	6.74e-05	0.000189	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	6.68e-05	0.000187	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	6.63e-05	0.000186	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	6.6e-05	0.000185	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	6.54e-05	0.000184	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	6.51e-05	0.000182	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	6.4e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	6.35e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	6.34e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.34e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	6.3e-05	0.000177	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	6.27e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	6.13e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	6.07e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SRC—pancreatic cancer	6.03e-05	0.000169	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	5.91e-05	0.000166	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	5.88e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	5.85e-05	0.000164	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	5.82e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	5.8e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.76e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	5.74e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	5.71e-05	0.00016	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	5.58e-05	0.000157	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	5.57e-05	0.000156	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MYC—pancreatic cancer	5.41e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	5.39e-05	0.000151	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	5.36e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	5.33e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SRC—pancreatic cancer	5.29e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	5.29e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	5.18e-05	0.000145	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	5.15e-05	0.000145	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	5.13e-05	0.000144	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	5.1e-05	0.000143	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	5.09e-05	0.000143	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	5e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	5e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	4.95e-05	0.000139	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	4.85e-05	0.000136	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	4.82e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MYC—pancreatic cancer	4.74e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	4.73e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	4.7e-05	0.000132	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	4.64e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	4.59e-05	0.000129	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SRC—pancreatic cancer	4.47e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TP53—pancreatic cancer	4.44e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	4.38e-05	0.000123	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	4.36e-05	0.000122	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	4.31e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	4.3e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	4.25e-05	0.000119	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	4.02e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MYC—pancreatic cancer	4.01e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	4e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	3.92e-05	0.00011	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TP53—pancreatic cancer	3.89e-05	0.000109	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	3.75e-05	0.000105	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	3.72e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	3.7e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	3.4e-05	9.54e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TP53—pancreatic cancer	3.29e-05	9.23e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	3.29e-05	9.22e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	3.15e-05	8.83e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	2.78e-05	7.79e-05	CbGpPWpGaD
